← Back to news

Markets

BioMarin Pharmaceutical Q4 Earnings Call Highlights

Y

Wheat Falls on Monday

Y

Corn Holds Steady on Monday

Y

Forward Air says strategic review nearing conclusion

Y

Bed Bath & Beyond (BBBY) Earnings Transcript

Y

Trump-backed crypto stablecoin dips following 'attack,' quickly recovers

Y

Ultra Clean (UCTT) Earnings Call Transcript

Y

White House Takes The Wheel On The Stablecoin Bill As Yield Debate Narrows

Y

Daily ETF Flows: QQQ Takes No.1 Spot

Y

Carvana Profit Roars Higher, But Its Stock Price Is Sputtering

Y

Viral Doomsday Report Lays Bare Wall Street’s Deep Anxiety About AI Future

Y

Standard Chartered predicts Treasury bill demand surge to $1 trillion

Y

Forward Air (FWRD) Q4 2025 Earnings Transcript

Y

Supreme Court ruling throws Trump administration's tariff strategy into flux. What it means for global trade, U.S. economy

F

Whirlpool Stock Sags After Plan to Sell New Shares Disclosed

Y

Offerpad (OPAD) Q4 2025 Earnings Call Transcript

Y

Wall Street regulator allows intraday trading of tokenized WisdomTree money market fund

Y

SpaceX Rival Rises On New Defense Contract

Y

PayPal Pops On Buyout Buzz After Sudden CEO Change

Y

Robert Kiyosaki warns biggest stock market plunge still coming and ‘now imminent.’ How to shatterproof your nest-egg now

Y

Trump's Tariffs Lift Gold Prices. These Mining Stocks Are Basing.

Y

Earnings live: Hims & Hers stock slides, Domino's rises as investors await crucial update from Nvidia

Y

Paramount submits higher offer for Warner Bros Discovery in bid to block Netflix, source says (February 23)

Y

Viral Research Post On AI Risks Spooks Investors. DoorDash, American Express Among Stocks Taking A Hit.

Y

Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition

Y

Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook

Y

Novo Nordisk Stock Is Deeply Oversold on Weight Loss Drug Fail. Should You Buy the Dip?

Y

Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7%

Y

Stocks Finish Sharply Lower on Trade Uncertainty and AI-Disruption Fears

Y

Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay

Y

Sanofi’s (SNY) R&D Track Record Remains Investor Concern, Says BofA

Y

Should You Buy Dell Stock Before February 26? This Analyst Says Yes.

Y

Analysts Tout Three Chip Stocks Hovering Around Buy Zones

Y

Truist Lowers Neurocrine Biosciences, Inc.’s (NBIX) PT Following 2026 Outlook Update

Y

Hims & Hers Health, Inc. (HIMS) Expands Global Footprint With Eucalyptus Acquisition

Y

Hims & Hers forecasts 2026 revenue above estimates

Y

Alphabet Inc. (GOOGL): Loblaw Companies Limited Enters into New Collaboration

Y

Innodata Inc. (INOD) Expands Role as AI Data Engineering Partner

Y

Recursion Pharmaceuticals, Inc. (RXRX) Advances AI Drug Discovery Amid Market Shifts

Y

Citi Lowers PT on Broadcom Inc. (AVGO) Stock

Y

Goldman Sachs Raises PT on Arista Networks, Inc. (ANET) Stock

Y

Accenture Struck a Deal With OpenAi. The Stock Is Still Sliding Despite New OpenAI Deal.

Y

Cloudflare, Inc. (NET) Enters into Strategic Partnership with Mastercard Incorporated

Y

Bitcoin Had a Rough Weekend. Here's What Drove the Near-5% Drop In the World's Largest Cryptocurrency.

Y

B. Riley Raises PT on Onto Innovation Inc. (ONTO) Stock

Y

Kalshi Clears 'Backlog' of Suspicious Activity, Plans to Disclose Actions Against Insider Trading

Y

How You Can Rebuild Your Emergency Fund — Even in an Uncertain Economy

Y

PayPal Has Attracted Takeover Interest. Does That Make PYPL Stock a Buy Here?

Y

Goldman Sachs Initiates Coverage of Credo Technology Group Holding Ltd (CRDO) Stock

Y

Brown Capital Dumps $42 Million of Manhattan Associates Amid Stock's 42% Pullback

Y